Skip to content
10-K/A

Annual Report

Eucrates Biomedical Acquisition Corp.

0001104659-21-151723

← back to feed
Filed
Dec 20, 2021 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Dec 20, 2021 13.46M sh
Operating Cash Flow FY 2020 · Dec 31, 2020 −$568.55K
Cash And Equivalents FY 2020 · Dec 31, 2020 $551.26K
Stockholders Equity restated FY 2020 · Dec 31, 2020 −$9.31M
Stockholders Equity FY 2020 · Aug 20, 2020 $0
Total Liabilities restated FY 2020 · Dec 31, 2020 $10.34M
Current Assets FY 2020 · Dec 31, 2020 $1.02M
Total Assets FY 2020 · Dec 31, 2020 $105.83M
Net Income restated FY 2020 · Dec 31, 2020 −$4.92M
Operating Income FY 2020 · Dec 31, 2020 −$151.05K